CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CNCE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/03/16	22 : 02	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/14	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 58	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 53	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 33	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 29	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 26	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/07	01 : 23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/06	23 : 47	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/06	23 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/03/06	23 : 01	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/25	06 : 06	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/25	06 : 03	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/16	22 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/16	22 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/16	22 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/15	21 : 00	Business Wire	Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/15	07 : 07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/15	04 : 36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CNCE	Concert Pharmaceuticals Inc
2023/02/13	23 : 26	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CNCE	Concert Pharmaceuticals Inc